1. Medtech Insight
  2. >>Business

Stryker’s Mako Robot Continues To Bite Orthopedic Surgery Competition

 
• By Reed Miller

The company said it expected Mako to continue to drive market share gains in hip and knee surgery. Stryker sold 51 Mako robotic orthopedic surgery systems in the third quarter, bringing the total installed base to 772.

Mako Shark - short fin - Image
• Source: shutterstock.com

Stryker Corp.'s Mako surgical robot is helping the company gain market share in the knee and hip surgery markets.

In the third quarter of 2019, Stryker sold 51 Mako robots, including 42 in the US, the company reported on 29 October. By comparison, Stryker sold 37 Mako systems, including 26 in the US, in the third quarter of 2018. The total installed base of Stryker systems is now 772, including 627 in the US

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Business

More from Medtech Insight

LSX Europe: Women’s Health Education Is The Key For Unlocking VC Investment

 
• By Natasha Barrow

Flo Health was the first femtech unicorn to be valued at over $1bn. But the company faced 49 investment rejections before reaching that status, Anna Klepchukova, the company’s chief medical officer, told the LSX World Congress Europe. THENA Capital’s Esther Reynal de St Michel Richardot talked through the firm’s gender-smart investment strategy.

Synchron And Apple Team Up To Use ‘Mind-Thought Connection’ To Control iPhones, iPads

 
• By Marion Webb

Apple and Synchron are teaming up to develop technologies that will one day allow people who can’t use their hands or voice to control iPhones, iPads and other Apple devices by using only their thoughts.

Abbott’s FreeStyle Libre CGM Reduces Cardiovascular Disease-Related Hospitalization

 
• By Natasha Barrow

The REFLECT studies showed a 78% reduction in cardiovascular disease-related hospitalization for people living with type 1 diabetes with prior low blood sugar episodes.